SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Frédéric de Blay, Virginie Doyen, Evelyne Bloch-Morot, Daniel Caillot, Jacques Gayraud, Aymar de Laval, Alain Thillay, French application of the European guidelines for regulation of allergenic extracts, Journal of Allergy and Clinical Immunology, 2013, 131, 5, 1435

    CrossRef

  2. 2
    L. Tuppo, C. Alessandri, D. Pomponi, D. Picone, M. Tamburrini, R. Ferrara, M. Petriccione, I. Mangone, P. Palazzo, M. Liso, I. Giangrieco, R. Crescenzo, M. L. Bernardi, D. Zennaro, M. Helmer-Citterich, A. Mari, M. A. Ciardiello, Peamaclein – A new peach allergenic protein: similarities, differences and misleading features compared to Pru p 3, Clinical & Experimental Allergy, 2013, 43, 1
  3. 3
    S. Filep, A. Tsay, L. Vailes, G. Gadermaier, F. Ferreira, E. Matsui, E. M. King, M. D. Chapman, A multi-allergen standard for the calibration of immunoassays: CREATE principles applied to eight purified allergens, Allergy, 2012, 67, 2
  4. 4
    L. Englert, S. May, S. Kaul, S. Vieths, Die Therapieallergene-Verordnung, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2012, 55, 3, 351

    CrossRef

  5. 5
    Martin D. Chapman, Peter Briza, Molecular Approaches to Allergen Standardization, Current Allergy and Asthma Reports, 2012, 12, 5, 478

    CrossRef

  6. 6
    Sergio Bonini, Regulatory Aspects of Allergen-Specific Immunotherapy, World Allergy Organization Journal, 2012, 5, 10, 120

    CrossRef

  7. 7
    M. A. Calderón, F. E. R. Simons, H.-J. Malling, R. F. Lockey, P. Moingeon, P. Demoly, Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile, Allergy, 2012, 67, 3
  8. 8
    T. Bieber, H.-U. Simon, Allergen-specific immunotherapy: current concepts and future directions, Allergy, 2011, 66, 6